CELLective Dx Corporation's Series A Round

CELLective Dx Corporation raised a round of funding on October 23, 2006. Investors include Mohr Davidow Ventures.

CELLective Dx is an early-stage company developing a new generation of diagnostic tools for cancer based on analysis of CTCs directly from a patient's blood. Our novel proprietary technologies combine…

Articles about CELLective Dx Corporation's Series A Round: